Miguel López-Botet focuses on Molecular biology, Receptor, CD94/NKG2, NKG2 and Immunology. His Molecular biology research incorporates elements of T cell and CD8, Antigen. Miguel López-Botet interconnects Natural killer cell, NK Cell Lectin-Like Receptor Subfamily C, Human leukocyte antigen and Signal transduction, Cell biology in the investigation of issues within Receptor.
His NK Cell Lectin-Like Receptor Subfamily C research includes themes of Human cytomegalovirus and Virology. His research in CD94/NKG2 focuses on subjects like NK Cell Lectin-Like Receptor Subfamily D, which are connected to Monoclonal antibody and KLRB1. In his work, HLA-G is strongly intertwined with HLA-E, which is a subfield of NKG2.
Miguel López-Botet mostly deals with Immunology, Molecular biology, Receptor, Cell biology and T cell. The various areas that Miguel López-Botet examines in his Immunology study include Natural killer cell and Cytotoxic T cell. His Natural killer cell research is multidisciplinary, relying on both Interleukin 21 and Cytokine.
Miguel López-Botet has researched Molecular biology in several fields, including Cell culture, Antigen, CD94/NKG2, Interleukin 2 and Monoclonal antibody. His work in CD94/NKG2 addresses issues such as NK Cell Lectin-Like Receptor Subfamily D, which are connected to fields such as NK Cell Lectin-Like Receptor Subfamily C, Receptor complex and C-type lectin. Miguel López-Botet combines subjects such as HLA-E, Human leukocyte antigen, LILRB1 and MHC class I, NKG2 with his study of Receptor.
His primary areas of study are Immunology, Human cytomegalovirus, Receptor, Immunophenotyping and Human leukocyte antigen. His research links Cell with Immunology. The Human cytomegalovirus study combines topics in areas such as Natural killer cell, HLA-E, Serology and Degranulation.
The study incorporates disciplines such as Molecular biology, CD86 and MHC class II in addition to Natural killer cell. The concepts of his Receptor study are interwoven with issues in Phenotype, LILRB1 and Cell biology. His Human leukocyte antigen research incorporates themes from Gene, Immune system, Interferon type I and Antibody, Avidity.
Immunology, Receptor, Human leukocyte antigen, Antibody-dependent cell-mediated cytotoxicity and Acquired immune system are his primary areas of study. His Immunology study frequently draws connections between related disciplines such as Interleukin 12. His Receptor study integrates concerns from other disciplines, such as LILRB1, Cell growth and Genotype.
His studies in Human leukocyte antigen integrate themes in fields like Gene expression profiling, Biomarker, Internal medicine, Breast cancer and Antibody. His study on Antibody-dependent cell-mediated cytotoxicity also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
Ni Lee;Manuel Llano;Marta Carretero;Akiko Ishitani.
Proceedings of the National Academy of Sciences of the United States of America (1998)
A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells
Marco Colonna;Francisco Navarro;Teresa Bellón;Manuel Llano.
Journal of Experimental Medicine (1997)
IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS
Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar.
Immunology Today (1997)
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Mónica Gumá;Ana Angulo;Carlos Vilches;Natalia Gómez-Lozano.
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
Francisco Navarro;Manuel Llano;Teresa Bellón;Marco Colonna.
European Journal of Immunology (1999)
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
Mónica Gumá;Matthias Budt;Andrea Sáez;Tamara Brckalo.
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Mar Valés‐Gómez;Hugh T. Reyburn;Robert A. Erskine;Miguel López‐Botet.
The EMBO Journal (1999)
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer
Manuel Llano;Ni Lee;Francisco Navarro;Pilar García.
European Journal of Immunology (1998)
Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.
M Cebrián;E Yagüe;M Rincón;M López-Botet.
Journal of Experimental Medicine (1988)
The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
Marta Carretero;Claudia Cantoni;Teresa Bellón;Cristina Bottino.
European Journal of Immunology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: